G. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven Burrill.jpg)
Podcast
.jpg) |
Hear G. Steven Burrill's vision of healthcare in the year 2020 in a special podcast from The Journal of Life Sciences. |
News
Biotechs claw for their lifeblood - financing November 17, 2008 | Press Release
Biotech Visionary, G. Steven Burrill receives DiNA November 14, 2008 | Press Release
Redpoint Bio Retains Burrill & Co. to Advise on Strategic Alternatives November 12, 2008 | Press Release
See all NewsBurrill Biotechnology Report
The Burrill Biotechnology Report: Annual Subscription The Burrill Biotechnology Report has the detailed market intelligence you need each month to obtain an accurate overview of all the latest global developments and trends. › Learn More
Add to cart$1,999.00
The Burrill Biotechnology Report October 2008: Single Issue The Burrill Biotechnology Report has the detailed market intelligence you need each month to obtain an accurate overview of all the latest global developments and trends in the life sciences industry. › Learn More
Add to cart$299.00
The Burrill Biotechnology Report August/September 2008: Single Issue The Burrill Biotechnology Report has the detailed market intelligence you need each month to obtain an accurate overview of all the latest global developments and trends in the life sciences industry. › Learn More
Add to cart$299.00
The Burrill Biotechnology Report Excerpt August/September 2008: CEO Interview, Free with Registration Every issue, BBR will be publishing an “in depth” interview with a Biotech company CEO. We are extremely pleased to kick off this feature with George Scangos, CEO of Exelixis, who paints a very sobering picture of today’s turbulent economic climate and its impact on the biotech industry: With investors in risk-avoidance mode and demanding later and later data on lead products before they invest, where will the cash come from to conduct later trials in order to satisfy these demands? › Learn More